First Manhattan CO Seelos Therapeutics, Inc. Transaction History

First Manhattan CO

  • $31.9 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.59 - $1.04 $1,770 - $3,120
-3,000 Reduced 21.16%
11,175 $7,000
Q3 2022

Nov 14, 2022
SELL
$0.65 - $278.68 $7,014 - $3.01 Million
-10,792 Reduced 43.23%
14,175 $14,000
Q2 2022

Aug 15, 2022
BUY
$0.51 - $0.93 $1,530 - $2,790
3,000 Added 13.66%
24,967 $16,000
Q2 2021

Aug 16, 2021
BUY
$2.64 - $6.32 $25,858 - $61,904
9,795 Added 80.47%
21,967 $57,000
Q1 2021

May 14, 2021
BUY
$1.35 - $4.99 $16,432 - $60,738
12,172 New
12,172 $60,000

Others Institutions Holding SEEL

# of Institutions
1
Shares Held
40.5K
Call Options Held
0
Put Options Held
0
View Full List

About SEELOS THERAPEUTICS, INC.

SEEL Quotes by TradingView
  • Ticker SEEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 106,691,000
  • Market Cap $32M
  • Description
  • Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...
More about SEEL
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email